Skip to main content
Top
Published in: Cancer Causes & Control 6/2016

01-06-2016 | Commentary

50 % Response rates: half-empty, or half-full?

Authors: James V. Lacey Jr., Kristen E. Savage

Published in: Cancer Causes & Control | Issue 6/2016

Login to get access

Abstract

When the Black Women’s Health Study, a prospective cohort of over 59,000 women who have been followed since 1995, invited all of its participants to provide a DNA sample for future research, only 51 % of those participants agreed to do so. Responders were significantly older and more health conscious than non-responders. The Black Women’s Health Study is a unique resource, but this low level of response and its resulting self-selection bias are now the norm in contemporary epidemiologic, and especially cohort, studies. Epidemiology desperately needs new approaches that work better and cost less. The literature on predictors of response focuses too narrowly on participant characteristics and does not identify any clear steps studies can take to increase participation. To improve research quality, cost-efficiency, and long-term sustainability of studies, epidemiology can and should approach, analyze, and leverage response-rate data more creatively and extensively than most studies have done to date.
Literature
4.
go back to reference Campbell PT, Deka A, Briggs P, Cicek M, Farris AB, Gaudet MM, Jacobs EJ, Newton CC, Patel AV, Teras LR, Thibodeau SN, Tillmans L, Gapstur SM (2014) Establishment of the cancer prevention study II nutrition cohort colorectal tissue repository. Cancer Epidemiol Biomark Prev 23(12):2694–2702. doi:10.1158/1055-9965.EPI-14-0541 CrossRef Campbell PT, Deka A, Briggs P, Cicek M, Farris AB, Gaudet MM, Jacobs EJ, Newton CC, Patel AV, Teras LR, Thibodeau SN, Tillmans L, Gapstur SM (2014) Establishment of the cancer prevention study II nutrition cohort colorectal tissue repository. Cancer Epidemiol Biomark Prev 23(12):2694–2702. doi:10.​1158/​1055-9965.​EPI-14-0541 CrossRef
6.
go back to reference De Vries R, Tomlinson T, Kim H, Krenz C, Ryan K, Lehpamer N, Kim S (2016) The moral concerns of biobank donors: the effect of non-welfare interests on willingness to donate. Life Sci Soc Policy 12(3):1–15. doi:10.1186/s40504-016-0036-4 De Vries R, Tomlinson T, Kim H, Krenz C, Ryan K, Lehpamer N, Kim S (2016) The moral concerns of biobank donors: the effect of non-welfare interests on willingness to donate. Life Sci Soc Policy 12(3):1–15. doi:10.​1186/​s40504-016-0036-4
7.
10.
go back to reference Bunin GR, Spector LG, Olshan AF, Robison LL, Roesler M, Grufferman S, Shu XO, Ross JA (2007) Secular trends in response rates for controls selected by random digit dialing in childhood cancer studies: a report from the Children’s Oncology Group. Am J Epidemiol 166(1):109–116. doi:10.1093/aje/kwm050 CrossRefPubMed Bunin GR, Spector LG, Olshan AF, Robison LL, Roesler M, Grufferman S, Shu XO, Ross JA (2007) Secular trends in response rates for controls selected by random digit dialing in childhood cancer studies: a report from the Children’s Oncology Group. Am J Epidemiol 166(1):109–116. doi:10.​1093/​aje/​kwm050 CrossRefPubMed
11.
go back to reference Bernstein L, Allen M, Anton-Culver H, Deapen D, Horn-Ross PL, Peel D, Pinder R, Reynolds P, Sullivan-Halley J, West D, Wright W, Ziogas A, Ross RK (2002) High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States). Cancer Causes Control 13(7):625–635CrossRefPubMed Bernstein L, Allen M, Anton-Culver H, Deapen D, Horn-Ross PL, Peel D, Pinder R, Reynolds P, Sullivan-Halley J, West D, Wright W, Ziogas A, Ross RK (2002) High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States). Cancer Causes Control 13(7):625–635CrossRefPubMed
Metadata
Title
50 % Response rates: half-empty, or half-full?
Authors
James V. Lacey Jr.
Kristen E. Savage
Publication date
01-06-2016
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 6/2016
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-016-0748-z

Other articles of this Issue 6/2016

Cancer Causes & Control 6/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine